RC
AVNS

RGM Capital’s Avanos Medical AVNS Stock Holding History

RGM Capital’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,986,519
Closed -$47.5M – 21
2024
Q4 		$47.5M Sell
2,986,519
-184,936
-6% -$3.66M 1.96% 20
2024
Q3 		$76.2M Hold
3,171,455
– – 3.3% 17
2024
Q2 		$63.2M Hold
3,171,455
– – 2.53% 19
2024
Q1 		$63.1M Hold
3,171,455
– – 2.55% 19
2023
Q4 		$71.1M Buy
3,171,455
+219,764
+7% +$4.54M 2.92% 18
2023
Q3 		$59.7M Buy
2,951,691
+189,017
+7% +$4.28M 2.73% 15
2023
Q2 		$70.6M Buy
2,762,674
+109,570
+4% +$2.89M 3.15% 15
2023
Q1 		$78.9M Hold
2,653,104
– – 3.76% 14
2022
Q4 		$71.8M Sell
2,653,104
-125,000
-4% -$3.06M 4.18% 13
2022
Q3 		$60.5M Sell
2,778,104
-200,785
-7% -$5.25M 3.91% 14
2022
Q2 		$81.4M Buy
2,978,889
+21,264
+0.7% +$611K 4.25% 14
2022
Q1 		$99.1M Buy
2,957,625
+26,753
+0.9% +$862K 4.11% 15
2021
Q4 		$102M Buy
2,930,872
+408,942
+16% +$13.2M 4.23% 16
2021
Q3 		$78.7M Buy
2,521,930
+364,318
+17% +$12.4M 3.86% 15
2021
Q2 		$78.5M Buy
2,157,612
+235,957
+12% +$9.76M 3.63% 16
2021
Q1 		$84.1M Sell
1,921,655
-62,800
-3% -$2.95M 3.68% 16
2020
Q4 		$91M Sell
1,984,455
-70,898
-3% -$2.95M 3.97% 12
2020
Q3 		$68.3M Buy
2,055,353
+390,511
+23% +$12.5M 3.83% 15
2020
Q2 		$48.9M Buy
1,664,842
+257,877
+18% +$7.47M 2.95% 19
2020
Q1 		$37.9M Sell
1,406,965
-114,906
-8% -$3.43M 2.98% 15
2019
Q4 		$51.3M Buy
1,521,871
+309,185
+25% +$11.2M 2.93% 18
2019
Q3 		$45.4M Buy
1,212,686
+461,163
+61% +$17.6M 3.02% 18
2019
Q2 		$32.8M Buy
751,523
+708,806
+1,659% +$30.3M 2.36% 17
2019
Q1 		$1.82M Buy
+42,717
New +$1.91M 0.12% 19

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

RGM Capital's AVNS Position: Q1 2025 in Review

RGM Capital sold out of Avanos Medical (AVNS) in Q1 2025, closing a stake of 2,986,519 shares — an estimated $47.5M sold.

RGM Capital first reported a position in AVNS in Q1 2019 and held it in 24 quarters. The position peaked at $102M in Q4 2021. 277 funds tracked by Wall St. Rank hold AVNS as of Q1 2025.

  • RGM Capital reported no remaining Avanos Medical position as of Q1 2025 after selling out during the quarter.
  • RGM Capital sold 2,986,519 Avanos Medical shares in Q1 2025, an estimated $47.5M.
  • RGM Capital first reported a position in Avanos Medical in Q1 2019 and held it in 24 quarters.
  • RGM Capital's Avanos Medical position peaked at $102M in Q4 2021.
  • 277 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2025.

Based on RGM Capital's 13F filing for Q1 2025, filed 14 May 2025.